Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.

By E. Eisenstein, K. Anstrom, D. Kong, L. Shaw, R. Tuttle, D. Mark, J. Kramer, Robert A. Harrington, D. Matchar, D. Kandzari and 3 more. Journal of the American Medical Association (JAMA), 2007

903 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/e05777ec1d4b67bfe3a3f52feef7bb58c42a9abf

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. P. O'Gara
2. Rick A. Nishimura
3. J. Halperin
4. M. Mack
5. L. Fleisher
6. Judith Hochman
7. M. Creager
8. C. Yancy

In Surgery

1. Judith Hochman
2. M. Creager

Citations in the corpus

• Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D (2007, background): “Similarly, Eisenstein et al ( 21 ) reported an observational study in 4666 patients with follow-up at 6, 12, and 24 months after stenting.”
• Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study (2012, background): “Previous observational studies reported that premature discontinuation of thienopyridine therapy was the major determinant of stent thrombosis after implantation of drug-eluting stents(6) and that the extended use of clopidogrel in patients with drug-eluting stents may be associated with a reduced r”
• 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016, background): “, 2007 (48) 17148711 Aim: Assess the association between clopidogrel use and longterm clinical outcomes of pts receiving DES and BMS”
• 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesi (2011, positive): “Consensus in clinical practice is to treat DES patients for at least 12 months with DAPT to avoid late (after 30 days) stent thrombosis (497,501).”